Atlas Trials

Phase 2 STIR Trial: Haploidentical Transplant and Donor Natural Killer Cells for Solid Tumors

Clinical trial NCT02100891 · TERMINATED

Trial details

NCT number
NCT02100891
Sponsor
Monica Thakar
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Ewing SarcomaNeuroblastomaRhabdomyosarcomaOsteosarcomaCNS Tumors
Start date
2013-03-20
Primary completion
2020-06-08
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.